PRIVIA HEALTH GROUP INC
PRVANASDAQ🏆 #1427 by market capUS Equity
$340.15▼ $22.45 (−6.60%)
Simulated price1h—
24h▼ 6.6%
7d▲ 1319.1%
14d▲ 1309.7%
30d▲ 1119.8%
1y▲ 1541.7%
🏦Market Cap
$2.81B
Small Cap
📈Revenue Growth (YoY)
+24.1%
Healthy
📊Gross Margin
10.0%
Thin
💵FCF Margin
7.7%
Moderate
⚖️P/S Ratio
1.2x
Cheap
Otter Score
42
Weak
Trading Snapshot
- Day Range
- $336.81 – $342.85
- 52-Week Range
- $19.53 – $28.82
- Volume
- $1.73B
- Avg Volume
- $2.26B
- Shares Outstanding
- 126.0M
- Next Earnings
- Sep 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.32B
- Last Q Revenue
- $537M
- P/E Ratio
- 101.6
- P/S Ratio
- 1.2x
- EPS (TTM)
- $0.22
- Dividend Yield
- —
Why Investors Own PRVA
- ✓High-growth profile — revenue up +17.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 67% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2.32B▲ +20.8% YoY
Gross Margin (TTM)
67.3%▲ +3.7% YoY
Operating Income (TTM)
$774M▲ +20.8% YoY
Free Cash Flow (TTM)
$127M▲ +20.8% YoY
About PRIVIA HEALTH GROUP INC
A company profile for PRIVIA HEALTH GROUP INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
42/100
Analyst Price Target
ⓘAverage Target
$363.95
▲ +7.0% Upside
High Target$400.94
Low Target$288.87
Based on 31 analysts
Latest News & Updates
🚀
Barron’s·2h ago
PRIVIA HEALTH GROUP INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift PRVA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
PRIVIA HEALTH GROUP INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.